Prevalence of current and past COVID-19 in Ohio adults

医学 可信区间 2019年冠状病毒病(COVID-19) 置信区间 人口学 大流行 星团(航天器) 人口 限制 严重急性呼吸综合征冠状病毒2型(SARS-CoV-2) 整群抽样 预测区间 统计
作者
Abigail Norris Turner,David Kline,Alison Norris,W. Gene Phillips,Elisabeth Root,Jon Wakefield,Zhenfeng Li,Stanley Lemeshow,Morgan Spahnie,Amanda Luff,Yue Chu,Mary Kate Francis,Maria F. Gallo,Payal Chakraborty,Megan Lindstrom,Gerard Lozanski,William C. Miller,Samuel J. Clark
出处
期刊:Annals of Epidemiology [Elsevier]
标识
DOI:10.1016/j.annepidem.2021.11.009
摘要

Purpose To estimate the prevalence of current and past COVID-19 in Ohio adults. Methods We used stratified, probability-proportionate-to-size cluster sampling. During July 2020, we enrolled 727 randomly-sampled adult English- and Spanish-speaking participants through a household survey. Participants provided nasopharyngeal swabs and blood samples to detect current and past COVID-19. We used Bayesian latent class models with multilevel regression and poststratification to calculate the adjusted prevalence of current and past COVID-19. We accounted for the potential effects of non–ignorable non–response bias. Results The estimated statewide prevalence of current COVID-19 was 0.9% (95% credible interval: 0.1%–2.0%), corresponding to ∼85,000 prevalent infections (95% credible interval: 6,300–177,000) in Ohio adults during the study period. The estimated statewide prevalence of past COVID-19 was 1.3% (95% credible interval: 0.2%–2.7%), corresponding to ∼118,000 Ohio adults (95% credible interval: 22,000–240,000). Estimates did not change meaningfully due to non–response bias. Conclusions Total COVID-19 cases in Ohio in July 2020 were approximately 3.5 times as high as diagnosed cases. The lack of broad COVID-19 screening in the United States early in the pandemic resulted in a paucity of population-representative prevalence data, limiting the ability to measure the effects of statewide control efforts.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Vii应助MADKAI采纳,获得10
刚刚
李爱国应助MADKAI采纳,获得10
刚刚
李健应助MADKAI采纳,获得10
刚刚
烟花应助MADKAI采纳,获得20
刚刚
香蕉觅云应助MADKAI采纳,获得10
刚刚
科研通AI2S应助MADKAI采纳,获得10
刚刚
Singularity应助MADKAI采纳,获得10
刚刚
1秒前
1秒前
赘婿应助GGZ采纳,获得10
1秒前
阿盛完成签到,获得积分10
1秒前
1秒前
怕孤单的含羞草完成签到 ,获得积分10
2秒前
Muuu发布了新的文献求助10
2秒前
仁爱的乐枫完成签到,获得积分10
3秒前
3秒前
金润完成签到,获得积分10
4秒前
ZZ完成签到,获得积分10
4秒前
AteeqBaloch发布了新的文献求助10
5秒前
PaulLao完成签到,获得积分10
5秒前
5秒前
fleee发布了新的文献求助10
5秒前
5秒前
6秒前
Luyao发布了新的文献求助10
6秒前
海派Hi完成签到 ,获得积分10
6秒前
依依完成签到 ,获得积分10
7秒前
李健的小迷弟应助库外采纳,获得10
7秒前
yi完成签到 ,获得积分10
7秒前
kbj发布了新的文献求助10
7秒前
9秒前
佳言2009完成签到,获得积分10
10秒前
汉堡包应助漂亮的初蓝采纳,获得10
10秒前
hohokuz发布了新的文献求助10
11秒前
莫里完成签到,获得积分10
11秒前
zxz发布了新的文献求助10
11秒前
Luyao完成签到,获得积分10
12秒前
12秒前
12秒前
马甲完成签到,获得积分10
12秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527723
求助须知:如何正确求助?哪些是违规求助? 3107826
关于积分的说明 9286663
捐赠科研通 2805577
什么是DOI,文献DOI怎么找? 1539998
邀请新用户注册赠送积分活动 716878
科研通“疑难数据库(出版商)”最低求助积分说明 709762